Jade Biosciences, Inc. (JBIO) Free cash flow 2021–2025
Jade Biosciences, Inc. (JBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$94.9MFY2025 · since FY2021: -$27.6M → -$94.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$94.9M | — |
| FY2023 | -$56.9M | -44.8% |
| FY2022 | -$39.3M | -42.6% |
| FY2021 | -$27.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice